a public good project by the
Synthesis
Company
of California

© 2026

Seung Woon Paik | doi.page

0 works0 citations0 h-index

Seung Woon Paik

Sungkyunkwan University(KR)

Publications by Year

Research Areas

Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, Hepatitis B Virus Studies, Hepatitis C virus research, Liver Disease and Transplantation

Most-Cited Works

→ Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B(2005)1,515 cited
→ Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study(2013)766 cited
→ Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial(2016)685 cited
→ Hepatogastroenterology(2011)663 cited
→ Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection(2018)430 cited
→ Clinical usefulness of carbohydrate antigen 19‐9 as a screening test for pancreatic cancer in an asymptomatic population(2004)396 cited

→ Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: Analysis of prognostic factors(2012)

370 cited

→ Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series(2006)323 cited

→ HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B(2008)235 cited

→ Comparing the Outcomes of Radiofrequency Ablation and Surgery in Patients With a Single Small Hepatocellular Carcinoma and Well-Preserved Hepatic Function(2005)222 cited